This topic contains a solution. Click here to go to the answer

Author Question: Anxiolytics (minor tranquilizers) and antipsychotics (major tranquilizers) are likely to differ a ... (Read 111 times)

Shelles

  • Hero Member
  • *****
  • Posts: 582
Anxiolytics (minor tranquilizers) and antipsychotics (major tranquilizers) are likely to differ a great deal in terms of their
 
  a. efficacy in reducing the symptoms of schizophrenia
  b. ability to induce seizure activity
  c. ability to decrease muscle tone and tension
  d. all of these

Question 2

Drugs used to reduce parkinsonism symptoms induced by antipsychotic drugs generally possess
 
  a. anticholinergic properties
  b. antiadrenergic properties
  c. antiserotonergic properties
  d. antidopaminergic properties



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

marict

  • Sr. Member
  • ****
  • Posts: 304
Answer to Question 1

d

Answer to Question 2

a




Shelles

  • Member
  • Posts: 582
Reply 2 on: Jun 22, 2018
Thanks for the timely response, appreciate it


31809pancho

  • Member
  • Posts: 317
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

Pregnant women usually experience a heightened sense of smell beginning late in the first trimester. Some experts call this the body's way of protecting a pregnant woman from foods that are unsafe for the fetus.

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

Earwax has antimicrobial properties that reduce the viability of bacteria and fungus in the human ear.

Did you know?

Despite claims by manufacturers, the supplement known as Ginkgo biloba was shown in a study of more than 3,000 participants to be ineffective in reducing development of dementia and Alzheimer’s disease in older people.

For a complete list of videos, visit our video library